Doctor profile · Federal record
Dr. Shawn Peavie, D.O.
Endocrinology, Diabetes & Metabolism Physician (CMS: Endocrinology) · Cincinnati, OH
- NPI 1578899951
- Accepts Medicare
- MIPS 85.5 / 100 · 2023
- 17 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
4440 Red Bank RD, Suite 210
Cincinnati, OH 452272176
(513) 272-0313
fax (513) 272-0316
Credentials & registration
- NPI registered
- October 2009 — 17 yrs on file
- Profile last updated
- October 28, 2020
- Year of graduation
- 2009 — 17 yrs since
- Specialty taxonomy
- 207RE0101X — NUCC code
- State license (1)
- Ohio #34.010091
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1578899951. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
2,125
Distinct HCPCS
10
Medicare allowed
$92,518
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0897 |
Injection, denosumab, 1 mg | 1,200 | 12 | $23 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 356 | 184 | $119 | |
83036 |
Hemoglobin a1c level | 212 | 111 | $9 | |
95251 |
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 130 | 62 | $33 | |
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 69 | 37 | $78 | |
G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes | 53 | 26 | $52 | |
96372 |
Injection of drug or substance under skin or into muscle | 38 | 13 | $13 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 37 | 28 | $85 | |
99222 |
Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 17 | 17 | $128 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 13 | 13 | $158 |
In context: peer comparison
Among 17 peers in this city , average services per provider: 689. This provider delivers 3.1× the peer median.Open Payments
Industry payments received
All-time total
$36,925
Transactions
91
Manufacturers
6
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Xeris Pharmaceuticals, Inc. | 29 | $17,395.94 | |
| Dexcom, Inc. | 47 | $12,254.32 | |
| SANOFI-AVENTIS U.S. LLC | 8 | $6,842.36 | |
| AstraZeneca Pharmaceuticals LP | 5 | $248.40 | |
| Boston Scientific Corporation | 1 | $145.12 | |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $39.24 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
2,321
Patients
713
Total drug cost
$1,585,810
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Levothyroxine Sodium | Generic | 381 | 119 | $6,350 |
| Ozempic (Semaglutide) | Brand | 260 | 75 | $392,660 |
| Farxiga (Dapagliflozin Propanediol) | Brand | 251 | 72 | $277,306 |
| Trulicity (Dulaglutide) | Brand | 208 | 52 | $318,716 |
| Metformin Hcl Er (Metformin Hcl) | Brand | 158 | 55 | $1,868 |
| Novolog Flexpen (Insulin Aspart) | Brand | 138 | 49 | $204,774 |
| Synthroid (Levothyroxine Sodium) | Brand | 136 | 36 | $10,315 |
| Lantus Solostar (Insulin Glargine,hum.Rec.Anlog) | Brand | 130 | 45 | $96,717 |
| Metformin Hcl | Generic | 127 | 47 | $1,724 |
| Tresiba Flextouch U-100 (Insulin Degludec) | Brand | 94 | 29 | $72,633 |
Hospital affiliations
Frequently asked questions
What is Dr. Shawn Peavie's medical specialty?
Dr. Shawn Peavie practices Endocrinology, Diabetes & Metabolism Physician in Cincinnati, OH.
Where does Dr. Shawn Peavie practice?
Dr. Shawn Peavie practices at 4440 Red Bank RD, Cincinnati, OH 452272176. Office phone: 5132720313.
What is Dr. Shawn Peavie's NPI?
Dr. Shawn Peavie's National Provider Identifier (NPI) is 1578899951, issued by NPPES.
Does Dr. Shawn Peavie accept Medicare assignment?
Yes. Dr. Shawn Peavie accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Shawn Peavie commonly perform?
Top Medicare-reported procedures in 2023: Injection, denosumab, 1 mg (HCPCS J0897); Established patient office or other outpatient visit (HCPCS 99214); Hemoglobin a1c level (HCPCS 83036). Source: CMS Medicare Physician & Other Practitioners file.